The Relative Strength (RS) Rating for Harmony Biosciences (HRMY) stock jumped into a new percentile Thursday, with an increase from 70 to 83. This proprietary rating tracks market leadership by showing how a stock's price movement over the last 52 weeks compares to that of other stocks on the major indexes. Over 100 years of market history shows that the…
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.